China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

CPHI opened at $0.21 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The business has a 50 day simple moving average of $0.20 and a 200-day simple moving average of $0.22. China Pharma has a 12 month low of $0.13 and a 12 month high of $0.60.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.